ASCO: Treanda Combo Works in Indolent Lymphomas MedPage Today Note that the bendamustine-rituximab combination had significantly lower rates of a range of adverse events, including hair loss, leukocytopenia, neutropenia, and paresthesias compared with standard chemotherapy, although it had higher rates of skin ... |
